Delivery Order SPE2DR25D7905-SPE2DR26F8LDD
- Not listed
- The Defense Logistics Agency awarded a $3,444.77 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity). This firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias and...
- The Defense Logistics Agency awarded a delivery order valued at $2,512.96 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on a firm fixed-price basis. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12.5K delivery order on December 1, 2025, for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $1,291.09 delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 4, 2025, with completion targeted for November 5, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a $13,436.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/2 mL vials on September 25, 2025, with completion scheduled for September 26, 2025. This non-competitive, non-set-aside award is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for procurement of Procainamide 1 gram/10 milliliter vials with a ceiling value of $5,235.21. This firm fixed price delivery order was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,968.88 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract covers the supply of Procainamide 1 gram/10 milliliter vials (10 milliliter quantity), an antiarrhythmic medication used in cardiac care. This is a firm fixed-price delivery order with no set-aside designation, awarded through open...
- SPE2DR25D7905Indefinite Delivery Contract
- SPE2DR25D7905-SPE2DR26F8LDDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,532.88 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Procainamide is a cardiac antiarrhythmic medication used to treat abnormal heart rhythms and is a critical pharmaceutical commodity within military medical supply chains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical contracts across multiple therapeutic domains. As a prime contractor under the DLA Troop Support Medical vehicle, the company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating established capability to fulfill federal pharmaceutical procurement requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/25/25 |